HYDRAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydramine, and when can generic versions of Hydramine launch?
Hydramine is a drug marketed by Alpharma Us Pharms and is included in two NDAs.
The generic ingredient in HYDRAMINE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydramine
A generic version of HYDRAMINE was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDRAMINE?
- What are the global sales for HYDRAMINE?
- What is Average Wholesale Price for HYDRAMINE?
Summary for HYDRAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,144 |
| DailyMed Link: | HYDRAMINE at DailyMed |
Recent Clinical Trials for HYDRAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hamad Medical Corporation | Phase 4 |
US Patents and Regulatory Information for HYDRAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | HYDRAMINE | diphenhydramine hydrochloride | ELIXIR;ORAL | 080763-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alpharma Us Pharms | HYDRAMINE | diphenhydramine hydrochloride | SYRUP;ORAL | 070205-001 | Jan 28, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
